申请人:Hoelzemann Guenter
公开号:US20140228340A1
公开(公告)日:2014-08-14
Compounds of the formula I, in which R
1
, R
2
, X and Y have the meanings indicated in Claim
1
, are inhibitors of TBK1 and IKKε and can be employed, inter alia, for the treatment of cancer and inflammatory diseases.
式I中的化合物,其中R1、R2、X和Y具有权利要求1中指示的含义,是TBK1和IKKε的抑制剂,可用于治疗癌症和炎症性疾病。